viernes, 31 de octubre de 2014

¿Facilita la dexmedetomidina como adyuvante neuroaxial una mejor anestesia y analgesia? Revisión sistemática y meta-análisis

¿Facilita la dexmedetomidina como adyuvante neuroaxial una mejor anestesia y analgesia? Revisión sistemática y meta-análisis.


Does dexmedetomidine as a neuraxial adjuvant facilitate better anesthesia and analgesia? A systematic review and meta-analysis.
Wu HH, Wang HT, Jin JJ, Cui GB, Zhou KC, Chen Y, Chen GZ, Dong YL, Wang W.
PLoS One. 2014 Mar 26;9(3):e93114. doi: 10.1371/journal.pone.0093114. eCollection 2014.
Abstract
BACKGROUND: Neuraxial application of dexmedetomidine (DEX) as adjuvant analgesic has been invetigated in some randomized controlled trials (RCTs) but not been approved because of the inconsistency of efficacy and safety in these RCTs. We performed this meta-analysis to access the efficacy and safety of neuraxial DEX as local anaesthetic (LA) adjuvant. ...... CONCLUSION: Neuraxial DEX is a favorable LA adjuvant with better and longer analgesia. The greatest concern is bradycardia. Further large sample trials with strict design and focusing on long-term outcomes are needed.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966844/pdf/pone.0093114.pdf



Atentamente
Anestesiología y Medicina del Dolor
www.anestesia-dolor.org

No hay comentarios: